Optimi Health (FRA:8BN0) Tariff Resilience Score: 6/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8BN0 Optimi Health Corp FRA:8BN0
35 GF Score
Price €3.87
GF Value €3.51
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Optimi Health Tariff Resilience Score?

Optimi Health FRA:8BN0 +0.65% 35 Tariff Resilience Score is 6 as of Jul. 14, 2026. GuruFocus rates FRA:8BN0 with a GF Score™ of 35/100 and a GF Value™ of €3.51 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,029 Drug Manufacturers companies, Optimi Health ranks better than 91.06% on this metric.

Optimi Health has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Optimi Health has Health and wellness company with some international exposure. While tariffs could affect supply chain costs, the company has potential to adjust pricing and explore alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Optimi Health might have Average Resilient.

Optimi Health  (FRA:8BN0) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Optimi Health Tariff Resilience Score Related Terms

FRA:8BN0 vs ZTS, UTHR: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimi Health Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Optimi Health's Tariff Resilience Score falls into.


FRA:8BN0
35GF Score
Optimi Health Corp FRA:8BN0
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Optimi Health (FRA:8BN0) has a Tariff Resilience Score of 6 as of Jul. 14, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Optimi Health ranks #92 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is Optimi Health's Tariff Resilience Score too high?
Optimi Health's current Tariff Resilience Score is 6. Based on the distribution chart, Optimi Health ranks #92 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Optimi Health has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Tariff Resilience Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #92 out of 1029 companies for Tariff Resilience Score. This places Optimi Health in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Optimi Health's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (FRA:8BN0) is currently considered Fairly Valued. The stock's GF Value™ is €3.51, compared to a current price of €3.87 — trading 10.3% above its estimated fair value. The current Tariff Resilience Score is 6. Optimi Health's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Optimi Health (FRA:8BN0), the current Tariff Resilience Score is 6 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Optimi Health (FRA:8BN0) Overvalued in 2026?

Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued. The current stock price of €3.87 is trading 10.3% above its estimated GF Value™ of €3.51. GuruFocus considers Optimi Health to be Fairly Valued.

Key valuation signals for FRA:8BN0:

  • Tariff Resilience Score: 6
  • GF Value™: €3.51 vs. price of €3.87 (10.3% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the FRA:8BN0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optimi Health Business Description

Address 269 David Brown Way, Po Box 728, Princeton, BC, CAN, V0X 1W0
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
35GF Score

Get the complete analysis for FRA:8BN0

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.87
Price
€3.51
GF Value